Literature DB >> 17712864

Phage phiC31 integrase-mediated genomic integration and long-term gene expression in the lung after nonviral gene delivery.

Manish Kumar Aneja1, Rabea Imker, Carsten Rudolph.   

Abstract

BACKGROUND: Phage phiC31 integrase has emerged as a potent tool for achieving long-term gene expression in different tissues. The present study investigated the activity of phiC31 integrase in murine lungs.
METHODS: Transfections in murine alveolar epithelial (MLE12) cells were performed with Lipofectamine 2000. For in vivo gene delivery, DNA was complexed with polyethylenimine (PEI) and PEI-DNA complexes were injected intravenously into mice. Expression of luciferase in mice was monitored by in vivo bioluminsecence imaging. Genomic integration and integration into a previously described 'hotspot' were confirmed by polymerase chain reaction (PCR).
RESULTS: phiC31 integrase mediated intramolecular recombination between wild-type attB and attP sites in MLE12 cells. Long-term gene expression could be observed in MLE12 cells in the presence of integrase without any selection pressure. Long-term expression of luciferase after intravenous injection of PEI-DNA complexes could be observed only in the lungs of mice which were co-injected with the integrase-encoding plasmid. Increased amounts of integrase plasmid and administration of a second dose had no effect on the level of luciferase expression achieved with a single dose, which was three orders of magnitude lower than the values observed on 'day 1' post application. Genomic integration of the transgene in the mouse lungs was confirmed by PCR. Seven out of the fifteen treated mice showed integration at the mpsL1 site, a previously described 'hot spot' from liver.
CONCLUSIONS: These results provide evidence for the activity of phiC31 integrase in lungs but also emphasize the need for optimization of the system to maintain long-term gene expression at high levels. 2007 John Wiley & Sons, Ltd

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712864     DOI: 10.1002/jgm.1090

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  9 in total

Review 1.  Advances in cell and gene-based therapies for cystic fibrosis lung disease.

Authors:  Mayumi Oakland; Patrick L Sinn; Paul B McCray
Journal:  Mol Ther       Date:  2012-02-28       Impact factor: 11.454

2.  Expression of therapeutic proteins after delivery of chemically modified mRNA in mice.

Authors:  Michael S D Kormann; Günther Hasenpusch; Manish K Aneja; Gabriela Nica; Andreas W Flemmer; Susanne Herber-Jonat; Marceline Huppmann; Lauren E Mays; Marta Illenyi; Andrea Schams; Matthias Griese; Iris Bittmann; Rupert Handgretinger; Dominik Hartl; Joseph Rosenecker; Carsten Rudolph
Journal:  Nat Biotechnol       Date:  2011-01-09       Impact factor: 54.908

3.  Production of transgenic cattle highly expressing human serum albumin in milk by phiC31 integrase-mediated gene delivery.

Authors:  Yan Luo; Yongsheng Wang; Jun Liu; Hui Lan; Minghao Shao; Yuan Yu; Fusheng Quan; Yong Zhang
Journal:  Transgenic Res       Date:  2015-07-22       Impact factor: 2.788

4.  Bioluminescence imaging allows monitoring hepatitis C virus core protein inhibitors in mice.

Authors:  Juan Du; Fang Zhao; Yong Zhou; Hu Yan; Xiang-guo Duan; Sheng-qiang Liang; Ying-li Wang; Qiu-xia Fu; Xiao-hui Wang; Jian-chun Peng; Lin-sheng Zhan
Journal:  PLoS One       Date:  2010-11-18       Impact factor: 3.240

5.  Optimization of Streptomyces bacteriophage phi C31 integrase system to prevent post integrative gene silencing in pulmonary type II cells.

Authors:  Manish Kumar Aneja; Johannes Geiger; Rabea Imker; Senta Uzgun; Michael Kormann; Guenther Hasenpusch; Christof Maucksch; Carsten Rudolph
Journal:  Exp Mol Med       Date:  2009-12-31       Impact factor: 8.718

6.  Polyethylenimine-mediated gene delivery to the lung and therapeutic applications.

Authors:  Sante Di Gioia; Massimo Conese
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

7.  Cell type differences in activity of the Streptomyces bacteriophage phiC31 integrase.

Authors:  Christof Maucksch; Manish Kumar Aneja; Elisabeth Hennen; Alexander Bohla; Florian Hoffmann; Markus Elfinger; Joseph Rosenecker; Carsten Rudolph
Journal:  Nucleic Acids Res       Date:  2008-08-21       Impact factor: 16.971

8.  Improved site-specific recombinase-based method to produce selectable marker- and vector-backbone-free transgenic cells.

Authors:  Yuan Yu; Qi Tong; Zhongxia Li; Jinhai Tian; Yizhi Wang; Feng Su; Yongsheng Wang; Jun Liu; Yong Zhang
Journal:  Sci Rep       Date:  2014-02-28       Impact factor: 4.379

9.  Global mapping of binding sites for phic31 integrase in transgenic maden-darby bovine kidney cells using ChIP-seq.

Authors:  Lijuan Qu; Lei Wang; Xueyuan Zhu; Yan Zhang; Qiang Ou; Aying Ma; Fengying Sheng; Xiaoqing Wei; Yue Dai; Guoting Li; Shuwu Xie
Journal:  Hereditas       Date:  2019-01-14       Impact factor: 3.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.